CVD Risk and Health in Postmenopausal Phytoestrogen Users
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
To determine the acceptability and benefits of use of a dietary supplement of the
phytoestrogen, genistein, versus placebo on heart disease risk factors, bone density, and
psychosocial outcomes in postmenopausal women.